Medivir Ab【0GP7】銘柄情報

	リアルタイム株価	レベル2
Forex

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

41.70

買値

0.00

売値

0.00

出来高

0.00

0.00 日の範囲 0.00

41.70 52 週間の範囲 41.70

時価総額

4.394B

前日終値

41.70

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

0.00

発行済株式数

105,371,000

配当利回り

PER

-49.19

1 株当たり利益 (EPS)

-0.85

歳入

7.66M

純利益

-89.32M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Diversified

ウェブサイト

www.medivir.se

本社

Huddinge, Swe

設立

1992

Medivir Ab is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker 0GP7. The last closing price for Medivir Ab was SEK41.70. Over the last year, Medivir Ab shares have traded in a share price range of SEK 41.70 to SEK 41.70.

Medivir Ab currently has 105,371,000 shares in issue. The market capitalisation of Medivir Ab is SEK4.39 billion. Medivir Ab has a price to earnings ratio (PE ratio) of -49.19.

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox PR Newswire STOCKHOLM, Jan. 15, 2024 STOCKHOLM, Jan. 15, 2024...

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR Newswire STOCKHOLM, Jan. 4, 2024 STOCKHOLM, Jan. 4, 2024...

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan PR Newswire STOCKHOLM, Dec. 19, 2023 Sustained disease control...

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval PR Newswire STOCKHOLM, Dec. 13, 2023 STOCKHOLM...

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB...

Medivir to present at the Carlsquare Equity Research Investor Day

Medivir to present at the Carlsquare Equity Research Investor Day PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

Bulletin from Extraordinary General Meeting in Medivir AB (publ)

Bulletin from Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Dec. 1, 2023 STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Today on 1 December 2023, Medivir AB (publ) (the...

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC PR Newswire STOCKHOLM, Nov. 27, 2023 STOCKHOLM, Nov. 27...

Medivir to present at the Redeye Life Science Day

Medivir to present at the Redeye Life Science Day PR Newswire STOCKHOLM, Nov. 22, 2023 STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company...

Medivir to present at the Erik Penser Bank Company Event

Medivir to present at the Erik Penser Bank Company Event PR Newswire STOCKHOLM, Nov. 21, 2023 STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

期間 †	始値	高値	安値	平均出来高	VWAP
1	41.7	41.7	41.7	0	0	DE
4	41.7	41.7	41.7	0	0	DE
12	41.7	41.7	41.7	0	0	DE
26	41.7	41.7	41.7	0	0	DE
52	41.7	41.7	41.7	46	41.7	DE
156	41.7	41.7	41.7	48	41.7	DE
260	41.7	41.7	41.7	253	41.7	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
KBTK3 Business Technology Group Plc	92.50p (48.00%)	9.55k
PIPPipehawk Plc	1.85p (37.04%)	835.95k
CMETCapital Metals Plc	2.10p (31.25%)	2.69M
APQApq Global Limited	6.50p (30.00%)	35k
GBPGlobal Petroleum Limited	0.365p (25.86%)	84.68M
GRLGoldstone Resources Limited	1.15p (-26.98%)	6.13M
ARBArgo Blockchain Plc	6.125p (-24.38%)	47.77M
HSSHss Hire Group Plc	5.00p (-16.11%)	596.73k
VRCIVerici Dx Plc	2.625p (-16.00%)	39.75k
BBBBigblu Broadband Plc	35.00p (-14.63%)	301.78k
ORCPOracle Power Plc	0.0385p (20.31%)	1.38B
PREMPremier African Minerals Limited	0.055p (0.92%)	367.45M
TRPTower Resources Plc	0.0305p (-1.61%)	240.81M
NTVONativo Resources Plc	0.0025p (0.00%)	231.54M
NTOGNostra Terra Oil And Gas Company Plc	0.0255p (0.00%)	126.93M